99 related articles for article (PubMed ID: 16912967)
1. The effect of tamoxifen on the pharmacokinetics of letrozole in female rats.
Tao X; Brodie AM; Nnane IP
Biopharm Drug Dispos; 2006 Oct; 27(7):335-44. PubMed ID: 16912967
[TBL] [Abstract][Full Text] [Related]
2. Biotransformation of letrozole in rat liver microsomes: effects of gender and tamoxifen.
Tao X; Piao H; Canney DJ; Borenstein MR; Nnane IP
J Pharm Biomed Anal; 2007 Feb; 43(3):1078-85. PubMed ID: 17045772
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of letrozole in male and female rats: influence of complexation with hydroxybutenyl-beta cyclodextrin.
Wempe MF; Buchanan CM; Buchanan NL; Edgar KJ; Hanley GA; Ramsey MG; Skotty JS; Rice PJ
J Pharm Pharmacol; 2007 Jun; 59(6):795-802. PubMed ID: 17637172
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the influence of modulation of P-glycoprotein by a multiple dosing regimen of tamoxifen on the pharmacokinetics and toxicodynamics of doxorubicin.
Darvari R; Boroujerdi M
Cancer Chemother Pharmacol; 2005 Nov; 56(5):497-509. PubMed ID: 15937726
[TBL] [Abstract][Full Text] [Related]
5. Gender difference in letrozole pharmacokinetics in rats.
Liu XD; Xie L; Zhong Y; Li CX
Acta Pharmacol Sin; 2000 Aug; 21(8):680-4. PubMed ID: 11501174
[TBL] [Abstract][Full Text] [Related]
6. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
Perucca E; Cloyd J; Critchley D; Fuseau E
Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Undaria pinnatifida Fucoidan on the Pharmacokinetics of Letrozole and Tamoxifen in Patients With Breast Cancer.
Tocaciu S; Oliver LJ; Lowenthal RM; Peterson GM; Patel R; Shastri M; McGuinness G; Olesen I; Fitton JH
Integr Cancer Ther; 2018 Mar; 17(1):99-105. PubMed ID: 28008779
[TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetics of letrozole in brain and brain tumor in rats with orthotopically implanted C6 glioma, assessed using intracerebral microdialysis.
Dave N; Gudelsky GA; Desai PB
Cancer Chemother Pharmacol; 2013 Aug; 72(2):349-57. PubMed ID: 23748921
[TBL] [Abstract][Full Text] [Related]
9. Reduction in tamoxifen-induced CYP3A2 expression and DNA adducts using antisense technology.
Mahadevan B; Arora V; Schild LJ; Keshava C; Cate ML; Iversen PL; Poirier MC; Weston A; Pereira C; Baird WM
Mol Carcinog; 2006 Feb; 45(2):118-25. PubMed ID: 16329150
[TBL] [Abstract][Full Text] [Related]
10. Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17.
Muss HB; Tu D; Ingle JN; Martino S; Robert NJ; Pater JL; Whelan TJ; Palmer MJ; Piccart MJ; Shepherd LE; Pritchard KI; He Z; Goss PE
J Clin Oncol; 2008 Apr; 26(12):1956-64. PubMed ID: 18332474
[TBL] [Abstract][Full Text] [Related]
11. Absolute bioavailability of letrozole in healthy postmenopausal women.
Sioufi A; Gauducheau N; Pineau V; Marfil F; Jaouen A; Cardot JM; Godbillon J; Czendlik C; Howald H; Pfister C; Vreeland F
Biopharm Drug Dispos; 1997 Dec; 18(9):779-89. PubMed ID: 9429742
[TBL] [Abstract][Full Text] [Related]
12. Effect of tamoxifen pretreatment on the pharmacokinetics, metabolism and cardiotoxicity of doxorubicin in female rats.
Vaidyanathan S; Boroujerdi M
Cancer Chemother Pharmacol; 2000; 46(3):185-92. PubMed ID: 11021735
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetic analysis of letrozole in Japanese postmenopausal women.
Tanii H; Shitara Y; Horie T
Eur J Clin Pharmacol; 2011 Oct; 67(10):1017-25. PubMed ID: 21494765
[TBL] [Abstract][Full Text] [Related]
14. Reduced prehepatic extraction of nicardipine in the presence of pioglitazone in rats.
Choi JS; Koh YY; Chung JH; Choi DH; Han HK
J Pharm Pharmacol; 2008 Oct; 60(10):1403-7. PubMed ID: 18812034
[TBL] [Abstract][Full Text] [Related]
15. Comparative bioavailability of letrozole under fed and fasting conditions in 12 healthy subjects after a 2.5 mg single oral administration.
Sioufi A; Sandrenan N; Godbillon J; Trunet P; Czendlik C; Howald H; Pfister C; Ezzet F
Biopharm Drug Dispos; 1997 Aug; 18(6):489-97. PubMed ID: 9267682
[TBL] [Abstract][Full Text] [Related]
16. Pathological effects of dietary zearalenone and/or tamoxifen on female mink reproductive organs.
Yamini B; Bursian SJ; Aulerich RJ
Vet Hum Toxicol; 1997 Apr; 39(2):74-8. PubMed ID: 9080630
[TBL] [Abstract][Full Text] [Related]
17. DNA damage and altered gene expression of enzymes for metabolism and DNA repair by tamoxifen and toremifene in the female rat liver.
Hashiba M; Kasahara T; Kim SY; Shibutani S; Degawa M
Cancer Sci; 2006 Jun; 97(6):468-77. PubMed ID: 16734724
[TBL] [Abstract][Full Text] [Related]
18. Fexofenadine in horses: pharmacokinetics, pharmacodynamics and effect of ivermectin pretreatment.
Olsén L; Ingvast-Larsson C; Larsson P; Broström H; Bondesson U; Sundqvist M; Tjälve H
J Vet Pharmacol Ther; 2006 Apr; 29(2):129-35. PubMed ID: 16515667
[TBL] [Abstract][Full Text] [Related]
19. Effects of letrozole on hippocampal and cortical catecholaminergic neurotransmitter levels, neural cell adhesion molecule expression and spatial learning and memory in female rats.
Aydin M; Yilmaz B; Alcin E; Nedzvetsky VS; Sahin Z; Tuzcu M
Neuroscience; 2008 Jan; 151(1):186-94. PubMed ID: 18061360
[TBL] [Abstract][Full Text] [Related]
20. Effects of aromatase inhibitors letrozole and anastrazole on bone metabolism and steroid hormone levels in intact female rats.
Kumru S; Yildiz AA; Yilmaz B; Sandal S; Gurates B
Gynecol Endocrinol; 2007 Oct; 23(10):556-61. PubMed ID: 17952760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
